44m
Korea Joongang Daily on MSNCelltrion's bone disease biosimilars get approval in U.S.Celltrion, a major Korean biopharmaceutical firm, said Tuesday that its two new biosimilars for bone disease treatment, Stoboclo and Osenvelt, have obtained approval from the United States.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results